怀孕期间与妊娠期糖尿病的复杂性
Richa Rattan1, Rimesh Pal1, Parul Chawla Gupta2
1Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India.
World journal of clinical cases
|January 7, 2025
概括
研究人员使用蛋白质组学在第二季度确定了潜在的妊娠糖尿病 (GDM) 生物标志物. 在GDM患者中观察到血清中视网醇结合蛋白4和血管蛋白类8的水平升高.
科学领域:
- 蛋白质组学是指蛋白质组学.
- 生物标志物发现发现
- 孕产妇健康 孕产妇健康
背景情况:
- 孕期糖尿病 (GDM) 对母亲和胎儿的健康构成风险.
- 早期识别GDM生物标志物对于及时干预至关重要.
- 蛋白质组技术为生物标志物发现提供了新的途径.
研究的目的:
- 为了确定早期的第二个三个月的生物标志物来预测GDM发展.
- 为了研究GDM患者的血清蛋白表达特征.
主要方法:
- 用于相对和绝对量化 (iTRAQ) 和液态染色体质谱法 (LC-MS) 的同位素标签.
- 分析了来自GDM患者和对照组的血清样本.
- 对蛋白质与蛋白质相互作用进行生物信息学分析.
主要成果:
- 在GDM组中鉴定出47种差异表达蛋白质.
- 在GDM患者中发现显著增加了视网醇结合蛋白4和血管蛋白类8的血清水平.
- 发现了一个潜在的蛋白质-蛋白质相互作用网络.
结论:
- 视网醇结合蛋白4和类似血管蛋白8是GDM的潜在生物标志物.
- 该研究强调需要进行更大规模的验证研究.
- 较早的GDM预测,可能是在第一季度,可能提供更大的临床实用性.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Pathophysiology of Diabetes
776
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
776
Diabetes Mellitus: Overview and Type I Subtype
2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Diabetes: Symptoms, Diagnosis, and Complications
466
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
466
Hypoglycemia and Glucagon
131
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
131
Diabetes: Management and Pharmacotherapy
203
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
203


